12:37 PM EDT, 09/10/2024 (MT Newswires) -- Teva Pharmaceutical Industries ( TEVA ) is expected to face a fine by European Union antitrust watchdog for being dismissive of a rival multiple sclerosis product competing with Copaxone, multiple sources reported Tuesday, citing people aware of the situation.

Teva didn't immediately respond to a request for comment from MT Newswires.

Price: 17.39, Change: -0.41, Percent Change: -2.33